Abstract: Vasopressin-2 receptor agonists, pharmaceutical compositions thereof and methods for using the foregoing for treating diabetes insipidus, primary nocturnal enuresis, and nocturia.

Abstract: Vasopressin-2 receptor agonists, pharmaceutical compositions thereof and methods for using the foregoing for treating diabetes insipidus, primary nocturnal enuresis, and nocturia.

Abstract: Vasopressin-2 receptor agonists, pharmaceutical compositions thereof and methods for using the foregoing for treating diabetes insipidus, primary nocturnal enuresis, and nocturia.

Abstract: A fabric structure used to make textured tissue or towel or nonwovens, the structure being permeable to air and water, comprising a sheet contact surface having a pattern including a series of raised land areas and corresponding depressions adapted to impart a texture to the tissue or towel or nonwoven, and a series of through voids adapted to allow passage of both water and/or air from the fabric surface into and/or through the structure.

Abstract: Vasopressin-2 receptor agonists, pharmaceutical compositions thereof and methods for using the foregoing for treating diabetes insipidus, primary nocturnal enuresis, and nocturia.

Abstract: A support member such as a belt or sleeve includes a topographical pattern on its sheet contact side. A plurality of land areas, corresponding depressions, through voids, and/or groove areas are formed on the top surface of the support member to produce the topographical pattern. The land areas, corresponding depressions, through voids, and/or groove areas may be formed by graving, cutting, etching, embossing, mechanical perforation or a combination thereof. The improved belt or sleeve imparts desired physical characteristics, such as bulk, appearance, texture, absorbency, strength, and hand to a nonwoven product produced thereon.

Abstract: A fabric structure used to make textured nonwoven products, the structure being permeable to air and water, comprising a web contact surface having a pattern including a series of raised land areas and corresponding depressions adapted to impart a texture to the nonwoven product produced thereon, and a series of through voids adapted to allow passage of both water and/or air from the fabric surface into and/or through the structure.

Abstract: Novel GLP-2 analogs with improved pharmacokinetic properties are described as well as their use in the treatment of disease.

Abstract: Novel GLP-2 analogs with improved pharmacokinetic properties are described as well as their use in the treatment of disease.

Abstract: The present application relates to novel compounds, pharmaceutical compositions comprising the same, use of said compounds for the manufacture of a medicament for treatment of inter alia shock conditions as well as to a method for treatment of said conditions, wherein said compounds are administered. The compounds are represented by the general formula (I), as further defined in the specification.

Abstract: The present invention relates to novel compounds, pharmaceutical compositions comprising the same, use of said compounds for the manufacture of a medicament for treatment of inter alia shock conditions as well as to a method for treatment of said conditions, wherein said compounds are administered. The compounds are represented by the general formula (I), as further defined in the specification.

Abstract: A fabric structure used to make textured tissue or towel or nonwovens, the structure being permeable to air and water, comprising a sheet contact surface having a pattern including a series of raised land areas and corresponding depressions adapted to impart a texture to the tissue or towel or nonwoven, and a series of through voids adapted to allow passage of both water and/or air from the fabric surface into and/or through the structure.

Abstract: A support member such as a belt or sleeve includes a topographical pattern on its sheet contact side. A plurality of land areas, corresponding depressions, through voids, and/or groove areas are formed on the top surface of the support member to produce the topographical pattern. The land areas, corresponding depressions, through voids, and/or groove areas may be formed by graving, cutting, etching, embossing, mechanical perforation or a combination thereof. The improved belt or sleeve imparts desired physical characteristics, such as bulk, appearance, texture, absorbency, strength, and hand to a nonwoven product produced thereon.

Abstract: A fabric structure used to make textured nonwoven products, the structure being permeable to air and water, comprising a web contact surface having a pattern including a series of raised land areas and corresponding depressions adapted to impart a texture to the nonwoven product produced thereon, and a series of through voids adapted to allow passage of both water and/or air from the fabric surface into and/or through the structure.

Abstract: The present invention relates to novel compounds, pharmaceutical compositions comprising the same, use of said compounds for the manufacture of a medicament for treatment of inter alia shock conditions as well as to a method for treatment of said conditions, wherein said compounds are administered. The compounds are represented by the general formula (I), as further defined in the specification.

Abstract: The present invention relates to novel compounds, pharmaceutical compositions comprising the same, use of said compounds for the manufacture of a medicament for treatment of pain and disorders related thereto as well as a method for treatment of pain and disorders related thereto, wherein said compounds are administered. The compounds are represented by the general formula (I), as further defined in the specification.

Abstract: A method and apparatus for forming a nonwoven product, including steps of forming a nonwoven web from a material and calendering the nonwoven web received following the forming step on a calender means. The method also including a step of obtaining information pertaining to a number of parameters of the calender means or to the formed nonwoven web from a sensor and controlling the calender means with the obtained information.

Abstract: Novel proteins or polypeptides having significant sequence homology to DPPIV, nucleic acids coding therefor, cells which have been modified with such nucleic acid so as to express these proteins, antibodies to these proteins, screening methods for the discovery of new therapeutic agents which are inhibitors of the activity of these proteins or of related proteins, and therapeutic agents discovered by such screening methods, as well as new therapeutic treatments, are all provided.

Abstract: (−)E-2-(3,4-dichlorocinnamyl)-1-cyclo-propylmethyl-piperidine of formula I: and its pharmaceutically acceptable salts, is useful for treating diarrhea in mammals. Also disclosed are pharmaceutical compositions, processes for preparing compounds of formula (I) and intermediates useful for preparing compounds of formula I.

Abstract: (−)E-2-(3,4-dichlorocinnamyl)-1-cyclopropylmethyl-piperidine of formula (I) and its addition salts with pharmaceutically acceptable acids; their use as antidiarrhoeals in mammals; pharmaceutical compositions intended for treatment of diarrhoeas.